MiMedx Group, Inc. (MDXG)
-NasdaqCM 4.81 
0.64(15.35%) Oct 1, 4:00PM EDT|After Hours
:
4.17 0.64 (13.31%) Oct 1, 6:20PM EDT
| Prev Close: | 4.17 |
|---|
| Open: | 4.46 |
|---|
| Bid: | 4.30 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 7.17 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | 30-Oct-13 |
|---|
| Day's Range: | 4.29 - 4.83 |
|---|
| 52wk Range: | 1.81 - 7.73 |
|---|
| Volume: | 959,295 |
|---|
| Avg Vol (3m): | 522,661 |
|---|
| Market Cap: | 463.56M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Why MiMedx Group Inc. Shares Surgedat Motley Fool(Tue, Oct 1)
- MiMedx® Signs Distribution Agreement With Medtronic®PR Newswire(Tue, Oct 1)
- ALERT: Rosen Law Firm Reminds MiMedx Group, Inc. Investors of Class Action Deadline -- MDXGGlobeNewswire(Fri, Sep 27)
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in MiMedx Group, Inc. of Class Action Lawsuit and Upcoming Deadline -- MDXGGlobeNewswire(Fri, Sep 27)
- Ryan & Maniskas, LLP Files Securities Fraud Class Action Against MiMedx Group, Inc.PR Newswire(Thu, Sep 26)
- MiMedx Responds To Misleading And Inaccurate Media ReportsPR Newswire(Wed, Sep 25)
- MiMedx® Adds Vice President of Medical AffairsPR Newswire(Tue, Sep 24)
- Saxena White P.A. Files Securities Fraud Class Action Against MiMedx Group, Inc.Marketwired(Thu, Sep 19)
- Wolf Haldenstein Announces Investigation of MiMedx Group, Inc.Business Wire(Thu, Sep 19)
- MiMedx® Ranked in Georgia's Top 100 Public CompaniesPR Newswire(Wed, Sep 18)
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MiMedx Group, Inc.Business Wire(Tue, Sep 17)
- Investor Alert: a Class Action Has Been Filed Against MiMedx Group, Inc.; Investors Encouraged to Inquire About Their Legal RightsMarketwired(Mon, Sep 16)
- Lawsuit on Behalf of Investors in MiMedx Group Inc (MDXG) Announced by Shareholders FoundationGlobeNewswire(Mon, Sep 16)
- Notice of Filing Securities Class Action Against MiMedx Group, Inc.Business Wire(Fri, Sep 13)
- MiMedx to meet with FDA in Mid-OctoberPR Newswire(Thu, Sep 12)
Key Statistics
| Forward P/E (1 yr): | 34.36 |
|---|
| P/S (ttm): | 9.23 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.01 |
|---|
| Quarterly EPS Est
(Sep-13)
: | 0.00 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | -28.33 |
|---|
Business Summary
MiMedx Group, Inc., together with its subsidiaries, operates as an integrated developer, manufacturer, and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membranes.
View More